243 related articles for article (PubMed ID: 27346730)
1. Zolpidem is a potent stoichiometry-selective modulator of α1β3 GABAA receptors: evidence of a novel benzodiazepine site in the α1-α1 interface.
Che Has AT; Absalom N; van Nieuwenhuijzen PS; Clarkson AN; Ahring PK; Chebib M
Sci Rep; 2016 Jun; 6():28674. PubMed ID: 27346730
[TBL] [Abstract][Full Text] [Related]
2. Probing the molecular basis for affinity/potency- and efficacy-based subtype-selectivity exhibited by benzodiazepine-site modulators at GABA
Söderhielm PC; Balle T; Bak-Nyhus S; Zhang M; Hansen KM; Ahring PK; Jensen AA
Biochem Pharmacol; 2018 Dec; 158():339-358. PubMed ID: 30121248
[TBL] [Abstract][Full Text] [Related]
3. Functional and molecular plasticity of γ and α1 GABA
Boychuk CR; Smith KC; Smith BN
J Neurophysiol; 2017 Nov; 118(5):2833-2841. PubMed ID: 28835522
[TBL] [Abstract][Full Text] [Related]
4. Actions of two GABAA receptor benzodiazepine-site ligands that are mediated via non-γ2-dependent modulation.
Leppä E; Linden AM; Rabe H; Vekovischeva OY; Wulff P; Lüddens H; Wisden W; Korpi ER
Eur J Pharmacol; 2011 Sep; 666(1-3):111-21. PubMed ID: 21616065
[TBL] [Abstract][Full Text] [Related]
5. GABA(A) receptor alpha-1 subunit deletion alters receptor subtype assembly, pharmacological and behavioral responses to benzodiazepines and zolpidem.
Kralic JE; O'Buckley TK; Khisti RT; Hodge CW; Homanics GE; Morrow AL
Neuropharmacology; 2002 Sep; 43(4):685-94. PubMed ID: 12367614
[TBL] [Abstract][Full Text] [Related]
6. The effects of zolpidem treatment and withdrawal on the in vitro expression of recombinant alpha1beta2gamma2s GABA(A) receptors expressed in HEK 293 cells.
Vlainić J; Jembrek MJ; Strac DS; Pericić D
Naunyn Schmiedebergs Arch Pharmacol; 2010 Sep; 382(3):201-12. PubMed ID: 20652804
[TBL] [Abstract][Full Text] [Related]
7. Etomidate produces similar allosteric modulation in α1β3δ and α1β3γ2L GABA(A) receptors.
Feng HJ; Jounaidi Y; Haburcak M; Yang X; Forman SA
Br J Pharmacol; 2014 Feb; 171(3):789-98. PubMed ID: 24199598
[TBL] [Abstract][Full Text] [Related]
8. The GABAA receptor alpha+beta- interface: a novel target for subtype selective drugs.
Ramerstorfer J; Furtmüller R; Sarto-Jackson I; Varagic Z; Sieghart W; Ernst M
J Neurosci; 2011 Jan; 31(3):870-7. PubMed ID: 21248110
[TBL] [Abstract][Full Text] [Related]
9. Cortical oscillatory dynamics and benzodiazepine-site modulation of tonic inhibition in fast spiking interneurons.
Prokic EJ; Weston C; Yamawaki N; Hall SD; Jones RS; Stanford IM; Ladds G; Woodhall GL
Neuropharmacology; 2015 Aug; 95():192-205. PubMed ID: 25797493
[TBL] [Abstract][Full Text] [Related]
10. GABA
Has ATC; Chebib M
Curr Pharm Des; 2018; 24(17):1839-1844. PubMed ID: 29766792
[TBL] [Abstract][Full Text] [Related]
11. A point mutation in the gamma2 subunit of gamma-aminobutyric acid type A receptors results in altered benzodiazepine binding site specificity.
Buhr A; Sigel E
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8824-9. PubMed ID: 9238062
[TBL] [Abstract][Full Text] [Related]
12. The effects of zolpidem treatment on GABA(A) receptors in cultured cerebellar granule cells: changes in functional coupling.
Vlainić J; Švob Štrac D; Jazvinšćak Jembrek M; Vlainić T; Peričić D
Life Sci; 2012 Jun; 90(23-24):889-94. PubMed ID: 22564411
[TBL] [Abstract][Full Text] [Related]
13. Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys.
Platt DM; Rowlett JK; Spealman RD; Cook J; Ma C
Psychopharmacology (Berl); 2002 Nov; 164(2):151-9. PubMed ID: 12404077
[TBL] [Abstract][Full Text] [Related]
14. Subtle changes in residue 77 of the gamma subunit of alpha1beta2gamma2 GABAA receptors drastically alter the affinity for ligands of the benzodiazepine binding site.
Buhr A; Baur R; Sigel E
J Biol Chem; 1997 May; 272(18):11799-804. PubMed ID: 9115236
[TBL] [Abstract][Full Text] [Related]
15. Engineered Flumazenil Recognition Site Provides Mechanistic Insight Governing Benzodiazepine Modulation in GABA
Siebert DCB; Bampali K; Puthenkalam R; Varagic Z; Sarto-Jackson I; Scholze P; Sieghart W; Mihovilovic MD; Schnürch M; Ernst M
ACS Chem Biol; 2018 Aug; 13(8):2040-2047. PubMed ID: 29989390
[TBL] [Abstract][Full Text] [Related]
16. The role of α1 and α5 subunit-containing GABAA receptors in motor impairment induced by benzodiazepines in rats.
Milić M; Divljaković J; Rallapalli S; van Linn ML; Timić T; Cook JM; Savić MM
Behav Pharmacol; 2012 Apr; 23(2):191-7. PubMed ID: 22327019
[TBL] [Abstract][Full Text] [Related]
17. Identification of amino acid residues responsible for the alpha5 subunit binding selectivity of L-655,708, a benzodiazepine binding site ligand at the GABA(A) receptor.
Casula MA; Bromidge FA; Pillai GV; Wingrove PB; Martin K; Maubach K; Seabrook GR; Whiting PJ; Hadingham KL
J Neurochem; 2001 Apr; 77(2):445-51. PubMed ID: 11299307
[TBL] [Abstract][Full Text] [Related]
18. Molecular and pharmacological characterization of native cortical gamma-aminobutyric acidA receptors containing both alpha1 and alpha3 subunits.
Araujo F; Tan S; Ruano D; Schoemaker H; Benavides J; Vitorica J
J Biol Chem; 1996 Nov; 271(44):27902-11. PubMed ID: 8910390
[TBL] [Abstract][Full Text] [Related]
19. Zolpidem modulation of phasic and tonic GABA currents in the rat dorsal motor nucleus of the vagus.
Gao H; Smith BN
Neuropharmacology; 2010 Jun; 58(8):1220-7. PubMed ID: 20226798
[TBL] [Abstract][Full Text] [Related]
20. Zolpidem withdrawal induced uncoupling of GABA(A) receptors in vitro associated with altered GABA(A) receptor subunit mRNA expression.
Jembrek MJ; Vlainić J; Šuran J
Acta Neurobiol Exp (Wars); 2015; 75(2):160-71. PubMed ID: 26232993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
